Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | IDO1 | P14902 | 2/20 | 0.38 |
| ▸ | NOS3 | P29474 | 1/20 | 0.36 |
| ▸ | NOS1 | P29475 | 1/20 | 0.36 |
| ▸ | PPARG | P37231 | 1/20 | 0.36 |
| ▸ | PPARA | Q07869 | 1/20 | 0.36 |
| ▸ | ADRB2 | P07550 | 2/20 | 0.36 |
| ▸ | ADRB1 | P08588 | 2/20 | 0.36 |
| ▸ | ADRB3 | P13945 | 2/20 | 0.36 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.35 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.35 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.35 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.35 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.35 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.34 |
| ▸ | VHL | P40337 | 1/20 | 0.34 |
| ▸ | ELOC | Q15369 | 1/20 | 0.34 |
| ▸ | ELOB | Q15370 | 1/20 | 0.34 |
| ▸ | CA12 | O43570 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL649272 | 0.88 | IDO1 (0.44) | IDO1ADRB2ADRB1ADRB3TAAR1 | |
| SCHEMBL12722434 | 0.84 | ADRB2 (0.38) | LTA4HTSHRIDO1NOS3NOS1 | |
| SCHEMBL11979782 | 0.84 | TAAR1 (0.50) | IDO1TAAR1CA12CA1CA2 | |
| SCHEMBL22098171 | 0.83 | CYP4F2 (0.53) | LTA4HTSHRIDO1PPARACYP4F2 | |
| SCHEMBL1337524 | 0.81 | IDO1 (0.41) | IDO1PPARGPPARAADRB2ADRB1 | |
| SCHEMBL12936622 | 0.79 | MRGPRX4 (0.45) | TSHRIDO1PRSS1PRSS2PRSS3 | |
| SCHEMBL12134040 | 0.79 | ACACB (0.39) | IDO1ADRB2ADRB1ADRB3 | |
| SCHEMBL8750390 | 0.79 | TDP1 (0.40) | TSHRIDO1TAAR1CA2 | |
| SCHEMBL407132 | 0.79 | AGXT (0.54) | IDO1TAAR1CA1CA2CA9 | |
| SCHEMBL15261000 | 0.77 | IDO1 (0.38) | IDO1ADRB2ADRB1ADRB3TAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230333475-A1 | COMPOSITE MATERIAL COMPRISING A RELEASE MATERIAL AND A THERMOPOLYMER MATERIAL, AND USES THEREOF | TERECIRCUITS CORPORATION | 2023-10-19 | — | — | US | disclosed |
| US-20230130004-A1 | RELEASE LAYER COMPOSITION FOR TRANSFER OF COMPONENTS | TERECIRCUITS CORPORATION | 2023-04-27 | — | — | US | disclosed |
| US-20170044326-A1 | POLY(BETA-METHYL-DELTA-VALEROLACTONE) BLOCK POLYMERS | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2017-02-16 | — | — | US | disclosed |
| US-9512426-B2 | Method for rapidly evaluating performance of short interfering RNA with novel chemical modifications | SIRNA THERAPEUTICS, INC. (US) | 2016-12-06 | — | — | US | disclosed |
| US-20150132761-A1 | METHOD FOR RAPIDLY EVALUATING PERFORMANCE OF SHORT INTERFERING RNA WITH NOVEL CHEMICAL MODIFICATIONS | BANK OF AMERICA, N.A. | 2015-05-14 | — | — | US | disclosed |
| US-8877439-B2 | Method for rapidly evaluating performance of short interfering RNA with novel chemical modifications | SIRNA THERAPEUTICS, INC. (US) | 2014-11-04 | — | — | US | disclosed |
| US-20120252027-A1 | Method For Rapidly Evaluating Performance Of Short Interfering RNA With Novel Chemical Modifications | BANK OF AMERICA, N.A. | 2012-10-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120252027-A1 | Method For Rapidly Evaluating Performance Of Short Interfering RNA With Novel Chemical Modifications | NSUN2, NSUN3, SNRPE | LTA4H 2926/4885TSHR 929/4885IDO1 2887/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.